(Q54255971)

26 May 2018

title

Endoscopically acquired pancreatic cyst fluid microRNA 21 and 221 are associated with invasive cancer. (English)

1 reference

26 May 2018

1 reference

1 reference

1 reference

1 reference

12

Timothy R Donahue

1 reference

26 May 2018

author name string

James J Farrell

1

1 reference

26 May 2018

Paul Toste

2

1 reference

26 May 2018

Nanping Wu

3

1 reference

26 May 2018

Luyi Li

4

1 reference

26 May 2018

Jonathan Wong

5

1 reference

26 May 2018

Daniel Malkhassian

6

1 reference

26 May 2018

Linh M Tran

7

1 reference

26 May 2018

Xiaoyang Wu

8

1 reference

26 May 2018

Xinmin Li

9

1 reference

26 May 2018

David Dawson

10

1 reference

26 May 2018

Hong Wu

11

1 reference

26 May 2018

language of work or name

English

0 references

publication date

11 June 2013

1 reference

26 May 2018

The American Journal of Gastroenterology

published in

1 reference

26 May 2018

volume

108

1 reference

26 May 2018

page(s)

1352-1359

1 reference

26 May 2018

issue

8

1 reference

26 May 2018

Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA expression pattern in intraductal papillary mucinous neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Integrative survival-based molecular profiling of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Intraductal papillary mucinous neoplasms of the pancreas: an updated experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.167

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.167

1 reference

26 May 2018

PubMed ID

23752880

1 reference

26 May 2018